Segments - Micro Balloon Catheter Market by Type (Latex Micro Balloon Catheter and Silicone Micro Balloon Catheter), Application (Cardiovascular, Gastrointestinal, Neurovascular, and Urology), End-user (Hospitals, Clinics, and Ambulatory Surgical Center), Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024 – 2032
The global micro balloon catheter market size was USD 54.2 Billion in 2023 and is likely to reach USD 96.3 Billion by 2032, expanding at a CAGR of 6.6% during 2024–2032. The market growth is attributed to the increasing demand for the minimally invasive procedure.
Micro-balloon catheters are a type of medical device used in various medical procedures. They are designed to provide a temporary, controlled, and precise means of accessing and manipulating the body's internal structures. A micro-balloon catheter typically consists of a thin, flexible tube with a small, inflatable balloon at the tip. The balloon is designed to be inflated with a small amount of fluid, such as saline or air, to allow for precise control over the catheter's movement and positioning within the body.
The rising incidence of conditions like urinary retention, urinary incontinence, benign prostatic hyperplasia, and neurogenic bladder dysfunction has led to a growing need for catheterization as a treatment option for both short-term and long-term management. As a result, the market is expected to experience significant growth in the forecast period, driven by the emergence of mid-scale catheter manufacturers vying for a larger market share. For instance,
According to the World Health Organization (WHO), over 200 million people globally are affected by various urological disorders. In the US, these disorders impact nearly 25 million individuals, with women comprising 80% of this population, highlighting the significant burden of urological health issues on women's health.
AI-powered diagnostic tools improve the accuracy of diagnoses and treatment plans, leading to better patient outcomes. Moreover, the personalized medicine is expected to propel the global market. AI help in personalizing the treatment plans based on individual patient characteristics, such as genetic profiles and medical histories.
Increasing demand for the minimally invasive procedure is fueling the market. The increasing demand for minimally invasive procedures is a significant driver of the micro balloon catheter market. These procedures offer numerous benefits, including reduced recovery times, less scarring, and lower risk of complications. For instance,
In May 2023, BD launched a groundbreaking prefilled flush syringe, the BD PosiFlush SafeScrub, designed to revolutionize patient care by streamlining the flushing and disinfection process for IV catheters during clinical procedures. By ensuring the cleanliness and disinfection of catheters, this minimally invasive product plays a critical role in preventing Central Venous Catheter-Related Bloodstream Infections (CRBSIs)
High cost of development and production of micro balloon catheters is expected to constrain the global market. Development of micro balloon catheters requires significant investment in research and development, which is a barrier to entry for new companies. Furthermore, the limited reimbursement landscape for micro balloon catheters, which impacts the adoption and utilization of these devices.
Advances in materials science are enabling the development of new micro balloon catheter materials with improved properties. Additionally, the advances in imaging technology, such as MRI and CT scans, are enabling the development of new micro balloon catheter designs and applications. These advancements and developments are expected to offer emerging opportunity to the market.
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Micro Balloon Catheter Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017–2022 |
Forecast Period |
2024–2032 |
Segmentation |
Type (Latex Micro Balloon Catheter and Silicone Micro Balloon Catheter), Application (Cardiovascular, Gastrointestinal, Neurovascular, and Urology), End-user (Hospitals, Clinics, and Ambulatory Surgical Center), |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Boston Scientific Corporation; ConvaTec Group Plc; Cure Medical LLC; Edward Lifesciences; Hollister Incorporated; Medtronic; Smith Medical Inc.; and Teleflex Incorporated |
In terms of region, the global micro balloon catheter market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific dominates the global market in 2023 owing to increasing demand for minimally invasive procedures. Moreover, the increasing healthcare expenditure in this area is expected to fuel the regional market during the forecast period. Furthermore, the presence of major market players in this region is driving the regional market.
The market in North America is projected to grow at a significant pace in the years to come owing to the high adoption rates of micro balloons catheters. Additionally, the increasing advancements of in medical devices and technology is expected to boost the regional market during the forecast period.
Based on type, the micro balloon catheter market is bifurcated into latex micro balloon catheter and silicone micro balloon catheter. The silicone micro balloon catheter segment held the largest share in the global market in 2023 owing to its biocompatibility and reduced risk of adverse reactions. Moreover, the durability of silicone micro balloon catheters is making it a more reliable option and driving the segment.
The latex micro balloon catheter segment is anticipated to grow at a substantial CAGR during the forecast period due to its lower cost. Latex catheters are widely available and are easily sourced from various suppliers. Moreover, the latex micro balloon catheters are highly getting adopted by healthcare professionals, driving the segment.
On the basis of application, the global market is segregated into cardiovascular, gastrointestinal, neurovascular, and urology. The cardiovascular segment is anticipated to register a considerable CAGR in over the predicted period due to the growing prevalence of cardiovascular disease. Cardiovascular procedures are among the most common and in-demand procedures in the medical field, driving the demand for micro balloon catheters.
The gastrointestinal segment is projected to register a robust growth rate during the assessment years owing to the advancements in technology to improve the design and functionality. The demand for endoscopy procedures is increasing, driving the demand for micro balloon catheters. The prevalence of gastrointestinal diseases is increasing globally, driving the demand for micro balloon catheters.
On the basis of end-user, the micro balloon catheter market is segmented into hospitals, clinics, and ambulatory surgical center. The hospitals segment registers a robust growth rate in 2023 due to the growing demand of diagnostic procedures. Hospitals are increasingly adopting minimally invasive procedures, which require micro balloon catheters and driving the segment.
The micro balloon catheter market has been segmented on the basis of
Key players competing in the global micro balloon catheter market are Boston Scientific Corporation; ConvaTec Group Plc; Cure Medical LLC; Edward Lifesciences; Hollister Incorporated; Medtronic; Smith Medical Inc.; and Teleflex Incorporated.
These players utilize several development strategies, such as product launches and acquisitions, to boost their global presence. For instance,
In October 2023, B. Braun has launched the Introcan Safety 2 IV Catheter, an innovative product that incorporates multi-access blood control technology. This feature is designed to provide clinicians with enhanced protection against blood exposure each time the hub is accessed, promoting a safer and more efficient IV therapy experience.
In April 2023, Boston Scientific Corporation has published its 2022 Performance Report, highlighting the company's commitment to driving innovation in medical devices and therapies to enhance patient outcomes. The report also showcases the company's focus on environmental, social, and governance (ESG) initiatives, demonstrating its dedication to responsible business practices and sustainability.